Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

More Deaths Reported as Baxter Expands Heparin Recall

Posted by Jane Akre
Friday, February 29, 2008 10:14 PM EST
Category: Major Medical, Protecting Your Family
Tags: Heparin, FDA and Prescription Drugs, Defective Drugs, Medical Malpractice

The FDA expands the heparin recall while more deaths could be attributed to use of the drug.


The FDA reports additional patient deaths are possibly linked to the blood thinner heparin so the company is mounting a recall of all of the drug.  

Baxter International Inc. will recall the remaining lots of single and multi-dose injection and it will recall HEP-LOCK products.

Last month, Baxter recalled nine lots of heparin multi-dose after the drug’s use was linked to four deaths and hundreds of mysterious allergic reactions.

Most of those adverse events were attributed to the multi-dose vial of heparin.

Now 17 other deaths are being investigated because of a link to heparin, although the FDA reminds reporters that those patients were already very sick so a definitive cause-effect at this time has not been established.

The active ingredient in heparin is made from membranes of pig intestines supplied by a Chinese plant,Changzhou SPL, co-owned by a Wisconsin company, Scientific Protein Laboratories of Waunakee.

The FDA has finally completed its investigation of the facility after initially confusing the plant’s name with another that had been inspected while it had not.

In a heavily redacted report released Thursday, the FDA said the facility had overall quality control and problems with its equipment and cleanliness.    And there is some question about the source of pigs that are slaughtered at nearby Chinese village farms.

The FDA on its web site says some of the ingredients came “from an unacceptable workshop vendor” but has not sourced the "root cause" of the problems linked to Baxter’s heparin.

The last step of heparin manufacturing occurs at the company’s Cherry Hill, New Jersey facility, which has been okayed by the FDA.

Heparin is commonly used in emergency rooms and dialysis centers as a blood thinner to avoid clots. It is the same drug that was given in an accidental overdose to the newborn twins of actor Dennis Quaid. He and his wife are suing Baxter because the vials of the low dose and high dose heparin have a similar blue label which had led to confusion and deaths before the Quaid incident. 

Baxter is the largest maker of heparin. Still on the market is a premixed IV solution that does not come from China. U.S. supplies of heparin are said to be sufficient.

Heparin brought Bayer about $30 million in sales in 2007.  #

No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address


RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes